Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose atorvastatin before elective PCI to prevent periprocedural myocardial infarction
2007-005056-16Phase 2Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of atorvastatin in coronary arteriosclerosis and myocardial infarction (MI), sponsored by IRCCS Ospedale San Raffaele. Primary endpoint: Prevention of periprocedural myocardial infarction. Started Nov 2007; status: completed.
02
Drugs
atorvastatin
03
Conditions
coronary arteriosclerosismyocardial infarction (MI)
Beyond the preview
Go deeper on 2007-005056-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005056-16.